CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors
Hidefumi Inaba, Yosuke Kaido, Saya Ito, Tomonao Hirobata, Gen Inoue, Takakazu Sugita, Yuki Yamamoto, Masatoshi Jinnin, Hiroaki Kimura, Tomoko Kobayashi, Shintaro Iwama, Hiroshi Arima, Takaaki Matsuoka
Endocrinol Metab. 2022;37(1):84-95.   Published online February 28, 2022
DOI: https://doi.org/10.3803/EnM.2021.1282

Excel Download

Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors
Endocrinology and Metabolism. 2022;37(1):84-95   Crossref logo
Link1 Link2 Link3

Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature
Reviews in Endocrine and Metabolic Disorders. 2021;22(2):337-349   Crossref logo
Link1 Link2 Link3

A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes
Cancer Immunology, Immunotherapy. 2016;66(1):25-32   Crossref logo
Link1 Link2 Link3

Biomarkers for immune checkpoint inhibitors: The importance of tumor topography and the challenges to cytopathology
Cancer Cytopathology. 2017;126(1):11-19   Crossref logo
Link1 Link2

Diabetes Mellitus Secondary to Treatment with Immune Checkpoint Inhibitors
Current Oncology. 2019;26(1):111-114   Crossref logo
Link1 Link2 Link3

Diabetes mellitus induced by immune checkpoint inhibitors
Diabetes/Metabolism Research and Reviews. 2020;37(1):   Crossref logo
Link1 Link2 Link3 Link4

SUN-170 Development of Type 1 Diabetes Mellitus on Immune Checkpoint Inhibitor
Journal of the Endocrine Society. 2019;3(Supplement_1):   Crossref logo
Link1

Immune Checkpoint Inhibitors
Immune Checkpoint Inhibitors in Cancer. 2019;1-17   Crossref logo
Link1 Link2

Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers
Cancers. 2020;12(10):2768   Crossref logo
Link1

Immune checkpoint inhibitor–induced diabetes mellitus with pembrolizumab
BMJ Case Reports. 2022;15(1):e245846   Crossref logo
Link1